MyAverix Finance
NS · Healthcare
Ganga Pharmaceuticals Ltd (539680)
Pharmaceuticals & Biotechnology
Ganga Pharmaceuticals Ltd (539680) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $70.90M, P/E ratio is 70.59, net margin is 2.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 539680
Ganga Pharmaceuticals Ltd (539680) — FAQ
What is Ganga Pharmaceuticals Ltd's market cap?
Ganga Pharmaceuticals Ltd (539680) has a reported market cap of $70.90M (data as of 2026-07-10).
What is 539680's P/E ratio?
The price-to-earnings (P/E) ratio for Ganga Pharmaceuticals Ltd (539680) is 70.59 (data as of 2026-07-10).
Does Ganga Pharmaceuticals Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Ganga Pharmaceuticals Ltd (539680). Check the MyAverix Finance app for the latest dividend data.
What sector is Ganga Pharmaceuticals Ltd in?
Ganga Pharmaceuticals Ltd (539680) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is 539680 listed on?
539680 is listed on NS.
What is Ganga Pharmaceuticals Ltd's net margin?
Ganga Pharmaceuticals Ltd (539680) reports a net margin of 2.5% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.